NRx Pharmaceuticals Announces Final Clinical Trial Results: Superior Safety Combined with Similar Efficacy in the Trial of NRX-101 Compared to Lurasidone in Suicidal Bipolar Depression

RADNOR, Pa., May 6, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ( " NRx Pharmaceuticals " , the " Company " ), a clinical stage pharmaceutical company, today announced a statistically significant safety advantage of NRX-101 compared to...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials